These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32067964)

  • 21. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.
    Herpfer I; Lieb K
    CNS Drugs; 2005; 19(4):275-93. PubMed ID: 15813642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do Substance P and Neurokinin A Play Important Roles in the Control of LH Secretion in Ewes?
    Fergani C; Mazzella L; Coolen LM; McCosh RB; Hardy SL; Newcomb N; Grachev P; Lehman MN; Goodman RL
    Endocrinology; 2016 Dec; 157(12):4829-4841. PubMed ID: 27704950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
    Nizam E; Erin N
    Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.
    Jensen DD; Lieu T; Halls ML; Veldhuis NA; Imlach WL; Mai QN; Poole DP; Quach T; Aurelio L; Conner J; Herenbrink CK; Barlow N; Simpson JS; Scanlon MJ; Graham B; McCluskey A; Robinson PJ; Escriou V; Nassini R; Materazzi S; Geppetti P; Hicks GA; Christie MJ; Porter CJH; Canals M; Bunnett NW
    Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R.
    Chakraborty S; Nepiyushchikh Z; Davis MJ; Zawieja DC; Muthuchamy M
    Microcirculation; 2011 Jan; 18(1):24-35. PubMed ID: 21166923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats.
    Schank JR; Tapocik JD; Barbier E; Damadzic R; Eskay RL; Sun H; Rowe KE; King CE; Yao M; Flanigan ME; Solomon MG; Karlsson C; Cheng K; Rice KC; Heilig M
    Biol Psychiatry; 2013 Apr; 73(8):774-81. PubMed ID: 23419547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurokinin receptor antagonism: a patent review (2014-present).
    Muñoz M; Coveñas R
    Expert Opin Ther Pat; 2020 Jul; 30(7):527-539. PubMed ID: 32401556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The redox modulatory effects of SP/NK1R system: Implications for oxidative stress-associated disorders.
    Ebrahimi S; Alalikhan A; Aghaee-Bakhtiari SH; Hashemy SI
    Life Sci; 2022 May; 296():120448. PubMed ID: 35247438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinations of neurokinin receptor antagonists reduce visceral hyperalgesia.
    Kamp EH; Beck DR; Gebhart GF
    J Pharmacol Exp Ther; 2001 Oct; 299(1):105-13. PubMed ID: 11561069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurokinin-1 (NK₁) receptor antagonists as possible therapeutics for psychostimulant use disorders.
    Olive MF
    CNS Neurol Disord Drug Targets; 2015; 14(6):700-6. PubMed ID: 26022261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study.
    Nyman M; Eskola O; Kajander J; Jokinen R; Penttinen J; Karjalainen T; Nummenmaa L; Hirvonen J; Burns D; Hargreaves R; Solin O; Hietala J
    J Affect Disord; 2019 Jan; 242():188-194. PubMed ID: 30193189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and pharmacological antagonism of NK
    Sandweiss AJ; McIntosh MI; Moutal A; Davidson-Knapp R; Hu J; Giri AK; Yamamoto T; Hruby VJ; Khanna R; Largent-Milnes TM; Vanderah TW
    Mol Psychiatry; 2018 Aug; 23(8):1745-1755. PubMed ID: 28485408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurokinin 1 Receptor Antagonists for Pruritus.
    Alam M; Buddenkotte J; Ahmad F; Steinhoff M
    Drugs; 2021 Apr; 81(6):621-634. PubMed ID: 33675531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental area.
    Hether S; Misono K; Lessard A
    Neuroscience; 2013 Sep; 247():12-24. PubMed ID: 23673279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
    Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
    Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
    Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
    Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord.
    Marvizon JC; Wang X; Lao LJ; Song B
    Br J Pharmacol; 2003 Dec; 140(8):1389-98. PubMed ID: 14623771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis.
    Lau HY; Bhatia M
    J Pathol; 2006 Feb; 208(3):364-71. PubMed ID: 16369913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.